MYGN Related Analyst Ratings

Nov 11, 2009 08:39 AM Morgan Joseph Upgrades Myriad Genetics (MYGN) to Hold; Expect Positive Sales

Sep 28, 2009 05:43 PM Stephens Starts Myriad Genetics (MYGN) at Overweight

Aug 26, 2009 09:02 AM Benchmark Maintains a 'Hold' on Myriad Genetics (MYGN); Raises Price Target

Aug 26, 2009 08:43 AM Canaccord Adams Upgrades Myriad Genetics (MYGN) to Buy

Aug 4, 2009 08:33 AM William Blair Initiates Coverage on Myriad Genetics (MYGN) with an Outperform

Jul 17, 2009 08:30 AM Soleil Securities Initiates Coverage on Myriad Genetics (MYGN) with a Buy

Jul 1, 2009 11:39 AM RBC Downgrades Myriad Genetics (MYGN) to Sector Perform

Jul 1, 2009 10:13 AM Morgan Joseph Downgrades Myriad Genetics (MYGN) from Buy to Sell; Lowers Estimates

Jul 1, 2009 09:32 AM Benchmark Lowers Price Target on Myriad Genetics (MYGN) to $25 After Negative Preannouncement

Jul 1, 2009 09:29 AM Piper Jaffray Initiates Coverage on Myriad Pharmaceuticals (MYRX) with an Underweight; Pipeline Lacks Sufficient Data

Jul 1, 2009 09:01 AM Oppenheimer Downgrades Myriad Genetics (MYGN) to Perform

Jul 1, 2009 07:30 AM Piper Jaffray Transfers Coverage on Myriad Genetics (MYGN) to Overweight; Attractive Opportunity At Present Levels

May 19, 2009 08:20 AM Morgan Joseph Initiates Coverage on Myriad Genetics (MYGN) with a Buy; Strong Long-term Drivers

May 13, 2009 11:11 AM Canaccord Adams Reiterates a 'Hold' on Myriad Genetics (MYGN); Lowers Estimates & Price Target

May 5, 2009 10:06 AM Citi Maintains a 'Buy' on Myriad Genetics (MYGN); Sell-Off Overdone - Presents Buying Opportunity

Mar 24, 2009 01:08 PM Leerink Swann Starts Myriad Genetics (MYGN) at Outperform

Feb 3, 2009 02:13 PM Benchmark Capital Upgrades Myriad Genetics (MYGN) to Buy

Jan 5, 2009 09:40 AM Piper Jaffray Calls Myriad Genetics (MYGN) A Top 2009 Pick

Nov 21, 2008 08:48 AM Citi Upgrades Myriad Genetics (MYGN) to Buy

Nov 5, 2008 11:28 AM Benchmark Capital Downgrades Myriad Genetics (MYGN) from Buy

Nov 4, 2008 01:57 PM Piper Jaffray Reiterates a 'Buy' on Myriad Genetics (MYGN), Raises Price Target and Earnings Estimates

Nov 3, 2008 10:26 AM JPMorgan Selects 26 Small, Mid-Cap Stocks That Can Outperform

Oct 8, 2008 07:37 AM Oppenheimer Initiates Coverage on Myriad Genetics (MYGN) with an Outperform

Aug 19, 2008 02:39 PM Piper Jaffray Bumps Price Target on Myriad Genetics (MYGN) to $74

Jul 30, 2008 11:31 AM RBC Capital Upgrades Myriad Genetics (MYGN) to Outperform

Jun 30, 2008 11:16 AM Piper Jaffray Would Be Buyers of Myriad Genetics (MYGN) On Today's Sell-Off

Jun 30, 2008 08:35 AM RBC Upgrades Myriad Genetics (MYGN) to Sector Perform

Jun 11, 2008 02:18 PM Pacific Growth Starts Myriad Genetics (MYGN) at Neutral

Jun 5, 2008 10:48 AM Canaccord Starts Myriad Genetics (MYGN) at Sell; $41.50 PT

May 28, 2008 07:37 AM RBC Capital Starts Myriad Genetics (MYGN) at Underperform

May 22, 2008 09:13 AM Citi Maintains 'Hold' Rating on Myriad Genetics (MYGN)

Nov 28, 2007 08:38 AM GARP Research Initiates Coverage on Myriad Genetics (MYGN) with a Buy

Sep 18, 2007 08:55 AM Citigroup Starts Myriad Genetics (MYGN) at Hold

Jan 8, 2007 06:09 PM Cramer Positive on Gilead Sciences (GILD) Ahead of Biotech Conference

Dec 14, 2006 11:01 AM S&P Equity Research Downgrades Myriad Genetics (MYGN) to Hold

Nov 2, 2006 08:28 AM Banc of America Starts Myriad Genetics (MYGN) at Buy

Mar 17, 2006 07:01 AM UBS resumes coverage on Myriad Genetics (MYGN) at Buy

Mar 13, 2006 01:01 PM Piper Jaffray raises its price target on MYGN

Feb 10, 2006 07:18 AM JP Morgan Starts MYGN at Overweight

Feb 9, 2006 07:49 AM JMP Securities upgrades MYGN to Strong Buy

Aug 24, 2005 06:55 AM Merrill Lynch Upgrades MYGN

May 2, 2005 10:47 AM First Albany Reit Buy Rating on MYGN After Trial Missed Primary Endpoints